UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Evaluation of MCF10A as a Reliable Model for Normal Human Mammary Epithelial Cells

PloS one, 2015-07, Vol.10 (7), p.e0131285-e0131285

2015

Volltextzugriff (PDF)

Improving the Lives of Women With Ovarian Cancer

Clinical obstetrics and gynecology, 2024-06, Vol.67 (2), p.347-351

KARLAN, BETH Y.

2024

Volltextzugriff (PDF)

Ovarian cancer

Nature reviews. Disease primers, 2016-08, Vol.2 (1), p.16061-16061, Article 16061

2016

Volltextzugriff (PDF)

Secondary Somatic Mutations Restoring BRCA1/2 Predict Chemotherapy Resistance in Hereditary Ovarian Carcinomas

Journal of clinical oncology, 2011-08, Vol.29 (22), p.3008-3015

2011

Volltextzugriff (PDF)

Optimizing exosomal RNA isolation for RNA-Seq analyses of archival sera specimens

PloS one, 2018-05, Vol.13 (5), p.e0196913

2018

Volltextzugriff (PDF)

Association of Germline BRCA Pathogenic Variants With Diminished Ovarian Reserve: A Meta-Analysis of Individual Patient-Level Data

Journal of clinical oncology, 2021-06, Vol.39 (18), p.2016-2024

2021

Volltextzugriff (PDF)

Impact of beta blockers on epithelial ovarian cancer survival

Gynecologic oncology, 2012-11, Vol.127 (2), p.375-378

2012

Volltextzugriff (PDF)

Surgery for Ovarian Cancer

Fourth edition., 2023

Volltextzugriff (PDF)

Gene Expression Profile of BRCAness That Correlates With Responsiveness to Chemotherapy and With Outcome in Patients With Epithelial Ovarian Cancer

Journal of clinical oncology, 2010-08, Vol.28 (22), p.3555-3561

2010

Volltextzugriff (PDF)

Phase II, Open-Label, Randomized, Multicenter Study Comparing the Efficacy and Safety of Olaparib, a Poly (ADP-Ribose) Polymerase Inhibitor, and Pegylated Liposomal Doxorubicin in Patients With BRCA1 or BRCA2 Mutations and Recurrent Ovarian Cancer

Journal of clinical oncology, 2012-02, Vol.30 (4), p.372-379

2012

Volltextzugriff (PDF)

Secondary BRCA1 mutations in BRCA1-mutated ovarian carcinomas with platinum resistance

Cancer research (Chicago, Ill.), 2008-04, Vol.68 (8), p.2581-2586

2008

Volltextzugriff (PDF)

Platelets reduce anoikis and promote metastasis by activating YAP1 signaling

Nature communications, 2017-08, Vol.8 (1), p.310-15, Article 310

2017

Volltextzugriff (PDF)

Secondary mutations as a mechanism of cisplatin resistance in BRCA2 -mutated cancers

Nature, 2008-02, Vol.451 (7182), p.1116-1120

2008

Volltextzugriff (PDF)

Tumorgrafts as In Vivo Surrogates for Women with Ovarian Cancer

Clinical cancer research, 2014-03, Vol.20 (5), p.1288-1297

2014

Volltextzugriff (PDF)

A transcriptome-wide association study of high-grade serous epithelial ovarian cancer identifies new susceptibility genes and splice variants

Nature genetics, 2019-05, Vol.51 (5), p.815-823

2019

Volltextzugriff (PDF)

Genetic epidemiology of ovarian cancer and prospects for polygenic risk prediction

Gynecologic oncology, 2017-12, Vol.147 (3), p.705-713

2017

Volltextzugriff (PDF)

A COL11A1-correlated pan-cancer gene signature of activated fibroblasts for the prioritization of therapeutic targets

Cancer letters, 2016-11, Vol.382 (2), p.203-214

2016

Volltextzugriff (PDF)

Occult and subsequent cancer incidence following risk-reducing surgery in BRCA mutation carriers

Gynecologic oncology, 2016-11, Vol.143 (2), p.231-235

2016

Volltextzugriff (PDF)

BRCA1 germline mutations may be associated with reduced ovarian reserve

Fertility and sterility, 2014-12, Vol.102 (6), p.1723-1728

2014

Volltextzugriff (PDF)

Adverse Health Outcomes in Women Exposed In Utero to Diethylstilbestrol

The New England journal of medicine, 2011-10, Vol.365 (14), p.1304-1314

2011

Volltextzugriff (PDF)

A Collagen-Remodeling Gene Signature Regulated by TGF-β Signaling Is Associated with Metastasis and Poor Survival in Serous Ovarian Cancer

Clinical cancer research, 2014-02, Vol.20 (3), p.711-723

2014

Volltextzugriff (PDF)

Can molecular subtyping be used to triage women with advanced ovarian cancer to Primary Debulking Surgery or Neoadjuvant Chemotherapy?

Gynecologic oncology, 2019-02, Vol.152 (2), p.221-222

2019

Volltextzugriff (PDF)

Gynecologic Oncology 2017 Update: New Features and Expanded Scope

Gynecologic oncology, 2017-01, Vol.144 (1), p.1-2

Karlan, Beth Y

2017

Volltextzugriff (PDF)

Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer

JNCI : Journal of the National Cancer Institute, 2015-11, Vol.107 (11), p.1

2015

Volltextzugriff (PDF)

1 – 25 von 644

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(587)
Mit Volltextzugriff
(553)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(644)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Evaluation of MCF10A as a Reliable Model for Normal Human Mammary Epithelial Cells

Improving the Lives of Women With Ovarian Cancer

Ovarian cancer

Secondary Somatic Mutations Restoring BRCA1/2 Predict Chemotherapy Resistance in Hereditary Ovarian Carcinomas

Optimizing exosomal RNA isolation for RNA-Seq analyses of archival sera specimens

Association of Germline BRCA Pathogenic Variants With Diminished Ovarian Reserve: A Meta-Analysis of Individual Patient-Level Data

Impact of beta blockers on epithelial ovarian cancer survival

Surgery for Ovarian Cancer

Gene Expression Profile of BRCAness That Correlates With Responsiveness to Chemotherapy and With Outcome in Patients With Epithelial Ovarian Cancer

Phase II, Open-Label, Randomized, Multicenter Study Comparing the Efficacy and Safety of Olaparib, a Poly (ADP-Ribose) Polymerase Inhibitor, and Pegylated Liposomal Doxorubicin in Patients With BRCA1 or BRCA2 Mutations and Recurrent Ovarian Cancer

Secondary BRCA1 mutations in BRCA1-mutated ovarian carcinomas with platinum resistance

Platelets reduce anoikis and promote metastasis by activating YAP1 signaling

Anti-angiopoietin therapy with trebananib for recurrent ovarian cancer (TRINOVA-1): a randomised, multicentre, double-blind, placebo-controlled phase 3 trial

Secondary mutations as a mechanism of cisplatin resistance in BRCA2 -mutated cancers

Tumorgrafts as In Vivo Surrogates for Women with Ovarian Cancer

A transcriptome-wide association study of high-grade serous epithelial ovarian cancer identifies new susceptibility genes and splice variants

Genetic epidemiology of ovarian cancer and prospects for polygenic risk prediction

A COL11A1-correlated pan-cancer gene signature of activated fibroblasts for the prioritization of therapeutic targets

Occult and subsequent cancer incidence following risk-reducing surgery in BRCA mutation carriers

BRCA1 germline mutations may be associated with reduced ovarian reserve

Adverse Health Outcomes in Women Exposed In Utero to Diethylstilbestrol

A Collagen-Remodeling Gene Signature Regulated by TGF-β Signaling Is Associated with Metastasis and Poor Survival in Serous Ovarian Cancer

Can molecular subtyping be used to triage women with advanced ovarian cancer to Primary Debulking Surgery or Neoadjuvant Chemotherapy?

Gynecologic Oncology 2017 Update: New Features and Expanded Scope

Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer

Suchergebnisse filtern